首页> 美国卫生研究院文献>Annals of Translational Medicine >A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore TNM stage and lymphocyte-to-monocyte ratio

【2h】

A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore TNM stage and lymphocyte-to-monocyte ratio

机译：一种预测I期非小细胞肺癌患者生存率的新方法：基于巨噬细胞免疫评分TNM分期和淋巴细胞与单核细胞比率的列线图

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Annals of Translational Medicine
作者
Jiani Gao; Yijiu Ren; Haoyue Guo; Rui Mao; Huikang Xie; Hang Su; Yunlang She; Jiajun Deng; Minglei Yang; Biao Han; Yu Zhang; Jian Li; Dong Xie; Chang Chen;
展开▼
作者单位

展开▼
年(卷),期 2020(8),7
年度 2020
页码 -1
总页数 23
原文格式 PDF
正文语种
中图分类
关键词
Non-small cell lung cancer (NSCLC); lymphocyte-to-monocyte ratio (LMR); immunoscore;

机译：非小细胞肺癌（NSCLC）;淋巴细胞与单核细胞比率（LMR）;免疫评分;
入库时间 2022-08-21 11:35:01

相似文献

外文文献
中文文献
专利

1. P1.16-39 A Nomogram for Predicting Survival Of TNM8 Stage I Non-Small Cell Lung Cancer Patients to Tailor Potential Chemotherapy Candidates [J] . W. Liang, Y. Zeng, N. Mayne, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P1.16-39一种预测TNM8阶段的生存的载体患者，用于量身定制潜在的化疗候选者
2. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients [J] . Wang Jia, Wu Nan, Lv Chao, Journal of Cancer Research and Clinical Oncology . 2019,第2期

机译：是否应患有阶段IB非小细胞肺癌接受佐剂化疗吗？ AJCC TNM分期系统阶段IB患者第8和第7版的生存比较
3. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer [J] . Zeng Yuan, Mayne Nicholas, Yang Chi-Fu Jeffrey, Annals of surgical oncology . 2019,第7期

机译：用于预测TNM第8版阶段的癌症特异性存活的墨迹I非小细胞肺癌
4. Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer [C] . Jiangdian Song, Yali Zang, Weimin Li, Conference on Computer-Aided Diagnosis . 2017

机译：放射组学诺模图的开发和验证，用于IV期EGFR突变非小细胞肺癌的无进展生存期预测
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC) [O] . Zhulin Wu, Chensheng Ouyang, Lisheng Peng 2020

机译：一种基于免疫分数的新型拓图用于预测早期非小细胞肺癌患者存活（NSCLC）
7. A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio [O] . Jiani Gao, Yijiu Ren, Haoyue Guo, 2020

机译：一种预测阶段的阶段非小细胞肺癌患者存活的新方法：基于巨噬细胞免疫摩托，TNM阶段和淋巴细胞对单核细胞比的墨迹图

A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore TNM stage and lymphocyte-to-monocyte ratio

著录项

相似文献

相关主题

期刊订阅